Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide vs. Placebo for Alcohol Dependence
NCT00595556Phase 4Completed
- Sponsor
- UConn Health
- Start
- Jul 2006
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in alcohol dependence comparing Zonisamide with Placebo (2 arms). Primary endpoints: Change in Number of Heavy Drinking Days Per Week at 12 weeks and Weekly Rate of Change in Abstinent Days at 12 weeks. Started Jul 2006; status: completed.
02
Drugs
zonisamide
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00595556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00595556.